Advanced Diabetes Testing

HbA1c (glycated hemoglobin) measures the percentage of hemoglobin in your red blood cells that has glucose attached to it, reflecting your average blood sugar levels over the past two to three months. It is considered the gold standard for diabetes diagnosis and monitoring because it provides a longer-term view than a single glucose measurement. Normal HbA1c is below 5.7 percent, prediabetes is 5.7 to 6.4 percent, and diabetes is 6.5 percent or higher. For diagnosed diabetics, HbA1c targets are typically below 7 percent, though individual targets may vary.

No, fasting requirements vary by test type. HbA1c does not require fasting and can be done at any time of day, making it very convenient. Fasting glucose requires 8 to 12 hours of fasting (water allowed). The Oral Glucose Tolerance Test (OGTT) also requires fasting. Fasting insulin requires fasting for accurate interpretation. When tests are combined, which we often recommend for comprehensive assessment, fasting is needed to accommodate the glucose and insulin tests. We provide specific preparation instructions when you book your appointment.

Fasting glucose measures your blood sugar concentration at a single point in time after an overnight fast, providing a snapshot of your current glucose level. HbA1c reflects your average blood sugar over the preceding two to three months. Both tests are valuable for different reasons: fasting glucose can detect acute hyperglycemia and is useful for immediate management decisions, while HbA1c provides a more comprehensive picture of overall glucose control and is less affected by day-to-day variations, stress, or recent meals. Using both together gives the most complete assessment of your diabetes status.

Prediabetes is a metabolic state where blood sugar levels are higher than normal but not yet high enough to be classified as type 2 diabetes. It is diagnosed when fasting glucose is between 100 and 125 mg/dL, HbA1c is between 5.7 and 6.4 percent, or OGTT two-hour glucose is between 140 and 199 mg/dL. Prediabetes is a critical warning sign because approximately 5 to 10 percent of people with prediabetes progress to diabetes annually. However, with lifestyle modifications including weight loss of 5 to 7 percent, regular physical activity, and dietary changes, progression can be prevented or significantly delayed.

Testing frequency depends on your risk profile and current status. For adults over 45 with normal results, testing every three years is recommended. High-risk individuals (family history, overweight, previous gestational diabetes, or PCOS) should test annually or more frequently. Those with prediabetes should test at least annually with HbA1c and fasting glucose. For diagnosed diabetes, HbA1c testing every three months is recommended until targets are consistently met, then every six months for stable patients. Your doctor will customize the testing schedule based on your individual circumstances.

The OGTT is a more sensitive test for detecting diabetes and impaired glucose tolerance. After fasting overnight, a baseline blood glucose is measured, then you drink a standardized glucose solution (75 grams). Blood glucose is measured at one hour and two hours after drinking the solution. Normal two-hour glucose is below 140 mg/dL, impaired glucose tolerance is 140 to 199 mg/dL, and diabetes is 200 mg/dL or higher. The OGTT is particularly important for diagnosing gestational diabetes during pregnancy and for detecting diabetes that might be missed by fasting glucose alone.

Insulin resistance occurs when your body's cells become less responsive to insulin, the hormone that helps glucose enter cells for energy. The pancreas compensates by producing more insulin, resulting in high insulin levels even when glucose may still be in the normal range. This state often precedes type 2 diabetes by years. We can assess insulin resistance by measuring fasting insulin and calculating the HOMA-IR index. Identifying insulin resistance early allows for lifestyle interventions that can prevent progression to diabetes, including weight loss, exercise, and dietary modifications.

Gestational diabetes develops during pregnancy when hormonal changes increase insulin resistance beyond the body's ability to compensate. It typically develops in the second or third trimester and is diagnosed with OGTT screening, usually between 24 and 28 weeks of gestation. Gestational diabetes increases risks for both mother and baby but is highly manageable with dietary modification, blood sugar monitoring, and occasionally insulin therapy. Women who have had gestational diabetes have a significantly increased lifetime risk of developing type 2 diabetes and should undergo regular screening postpartum.